{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:27:17Z","timestamp":1792373237058,"version":"4.4.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.therap.2016.10.006","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T13:30:20Z","timestamp":1484227820000},"page":"475-482","source":"Crossref","is-referenced-by-count":3,"title":["Interaction pharmacocin\u00e9tique entre la forme mucoadh\u00e9sive de miconazole et le tacrolimus\u00a0: \u00e0 propos de 3\u00a0observations cliniques chez des patients greff\u00e9s"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8506-8228","authenticated-orcid":false,"given":"Marion","family":"Lepelley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Logerot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Fonrose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Villier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2016.10.006_bib0100","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2174\/1389200215666141125121511","article-title":"Drug interactions between nine antifungal agents and drugs metabolized by human cytochromes\u00a0P450","volume":"15","author":"Niwa","year":"2014","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.therap.2016.10.006_bib0105","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.102.037549","article-title":"Interaction of cytochrome P450\u00a03A inhibitors with P-glycoprotein","volume":"303","author":"Yasuda","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"10.1016\/j.therap.2016.10.006_bib0110","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1021\/jm021012t","article-title":"Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery","volume":"46","author":"Schwab","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.therap.2016.10.006_bib0115","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2125.2004.02154.x","article-title":"Comparison of the pharmacokinetics of miconazole after administration via a bioadhesive slow release tablet and an oral gel to healthy male and female subjects","volume":"58","author":"Cardot","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.therap.2016.10.006_bib0120","first-page":"1035","article-title":"Perioperative management of chronic treatment and medical devices. Preamble","volume":"28","year":"2009","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.therap.2016.10.006_bib0125","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1211\/0022357056118","article-title":"Effect of micafungin on cytochrome P450\u00a03A4\u00a0and multidrug resistance protein\u00a01\u00a0activities, and its comparison with azole antifungal drugs","volume":"57","author":"Sakaeda","year":"2005","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.therap.2016.10.006_bib0130","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1128\/AAC.01242-10","article-title":"Miconazole oral gel increases exposure to oral oxycodone by inhibition of CYP2D6\u00a0and CYP3A4","volume":"55","author":"Gr\u00f6nlund","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.therap.2016.10.006_bib0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00228-008-0556-9","article-title":"Oral voriconazole and miconazole oral gel produce comparable effects on the pharmacokinetics and pharmacodynamics of etoricoxib","volume":"65","author":"Hynninen","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.therap.2016.10.006_bib0140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1179\/2295333714Y.0000000089","article-title":"Miconazole buccal gel and risk for systemic bleeding: how certain topical formula can interfere with anticoagulants","volume":"70","author":"De Pauw","year":"2015","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.therap.2016.10.006_bib0145","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-2710.2010.01229.x","article-title":"Warfarin and miconazole oral gel interactions: analysis and therapy recommendations based on clinical data and a pharmacokinetic model","volume":"36","author":"Miki","year":"2011","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.therap.2016.10.006_bib0150","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11845-012-0862-1","article-title":"Warfarin and topical miconazole: the potential for a clinically significant interaction","volume":"182","author":"Ufondu","year":"2013","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.therap.2016.10.006_bib0155","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/sj.bdj.4811224","article-title":"Miconazole oral gel and drug interactions","volume":"196","author":"Pemberton","year":"2004","journal-title":"Br Dent J"},{"issue":"4","key":"10.1016\/j.therap.2016.10.006_bib0160","first-page":"251","article-title":"Augmentation de l\u2019activit\u00e9 anticoagulante de la fluindione par le miconazole en comprim\u00e9 mucoadh\u00e9sif","volume":"32","author":"Fuchs","year":"2013","journal-title":"J Pharm Clin"},{"key":"10.1016\/j.therap.2016.10.006_bib0165","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1017\/S1041610211002754","article-title":"Serotonin syndrome during treatment with low dose of escitalopram associated with miconazole mucoadhesive tablet: a suspected drug interaction","volume":"24","author":"Baptista","year":"2012","journal-title":"Int Psychogeriatr IPA"},{"key":"10.1016\/j.therap.2016.10.006_bib0170","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2165\/00003088-199631060-00004","article-title":"Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors","volume":"31","author":"Baumann","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.therap.2016.10.006_bib0175","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/11595560-000000000-00000","article-title":"A pharmacokinetic-pharmacodynamic model for predicting the impact of CYP2C9\u00a0and VKORC1\u00a0polymorphisms on fluindione and acenocoumarol during induction therapy","volume":"51","author":"Verstuyft","year":"2012","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"10.1016\/j.therap.2016.10.006_bib0180","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/FTD.0000000000000335","article-title":"Effects of miconazole oral gel on blood concentrations of tacrolimus and cyclosporine: a retrospective observational study","volume":"38","author":"Ishiwata","year":"2016","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.therap.2016.10.006_bib0185","unstructured":"ANSM. Th\u00e9saurus des interactions m\u00e9dicamenteuses. 2016. http:\/\/www.ansm.sante.fr [consult\u00e9 le 23\u00a0d\u00e9cembre\u00a02016]."},{"issue":"1","key":"10.1016\/j.therap.2016.10.006_bib0095","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/03602532.2016.1151037","article-title":"Clinical determinants of calcineurin inhibitor disposition: a mechanistic review","volume":"48","author":"Vanhove","year":"2016","journal-title":"Drug Metab Rev"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595717300033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595717300033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T08:09:32Z","timestamp":1554278972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595717300033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0040595717300033"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2016.10.006","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}